Debut Plus

₹44.65

■ +0 +0.00%

As of 10 Sept 2026 · delayed

BSE Listed

ST-ASM · ASM 1
What does ST-ASM · ASM 1 mean?
BSE · Short Term Additional Surveillance Measure (ASM 1)ST-ASM catches short bursts: a beta-adjusted close-to-close move beyond ±25% in 5 trading days (or ±40% in 15) combined with concentrated trading — or a 75%+ monthly range with fewer than 100–200 unique traders. Practical meaning: margins jump to 50–100% for a few weeks to cool a spike; it either lapses quickly or escalates into LT-ASM if the move sustains.Criteria: Short-term (5 / 15 / 30-day) price-volume abnormality — high-low and close-to-close price variation over the window. Adds 100% margin and a 5% (then 2%) price band.Exchange notice · 2026-08-13

Chandra Bhagat Pharma Limited (542934)

Volume: 0Avg Vol 1W: 3,800Avg Vol 1M: 4,90952W Range:₹29.7₹52.71
BSE www.cbcpharma.com AI Report
Key Ratios
Checked 9h ago
Market Cap₹52 Cr
Current Price₹44.65
Previous Close₹44.65
High / Low (52w)₹52.71 / ₹29.7
Volume0
Avg Vol (1W)3,800
Avg Vol (1M)4,909
Stock P/E33.04
Book Value₹38.45
Dividend Yield—
ROE—
ROA—
Revenue (TTM)—
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value—
EPS (TTM)—
P/B1.8
Debt / Equity0.59
50 DMA₹42.79
200 DMA₹48.52
Day change+0.00%
SurveillanceST-ASM · ASM 1
Price Chart
₹44.65▼ 12.37% · 1Y
₹76₹3068K
2025-09-10
2026-09-10

20-day avg volume: 5K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 30% YoY.
  • Net profit is growing year over year.
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹107 Cr₹94 Cr₹71 Cr₹96 Cr₹120 Cr₹233 Cr₹92 Cr₹120 Cr
EBITDA₹5 Cr₹3 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹6 Cr
Net Profit₹1 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹2 Cr₹1 Cr₹3 Cr
EPS13.380.550.251.061.22.031.144.04
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹83 Cr₹75 Cr₹72 Cr₹72 Cr₹61 Cr₹102 Cr₹102 Cr₹94 Cr
Total Liabilities₹68 Cr₹49 Cr₹46 Cr₹46 Cr₹33 Cr₹73 Cr₹72 Cr₹61 Cr
Equity₹14 Cr₹26 Cr₹26 Cr₹27 Cr₹27 Cr₹29 Cr₹30 Cr₹33 Cr
Total Debt————————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹8 Cr₹13 Cr₹6 Cr₹7 Cr₹-5 Cr₹10 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹-2 Cr₹-1 Cr₹0 Cr
Financing₹-6 Cr₹-10 Cr₹-4 Cr₹-6 Cr₹2 Cr₹-6 Cr
Free Cash Flow₹8 Cr₹13 Cr₹6 Cr₹7 Cr₹-5 Cr₹10 Cr
Shareholding
Promoter 73.02% Institutions 0% Public 26.98%
Efficiency & Working Capital
ROCE—
Interest Coverage3.1
Dividend Payout—
Debtor Days171 d
Inventory Days15 d
Payable Days100 d
Cash Conversion Cycle86 d
Working Capital Days186 d
Shareholding Details

As of 2026-03-31

Promoter73%
FII0%
DII0%
Institutions0%
Public27%
Promoter Pledge0%
No. of Shareholders280
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2020Mar 2021Sept 2021Mar 2022Sept 2022Mar 2023Sept 2023Mar 2024Sept 2024Mar 2025Sept 2025Mar 2026
Promoters—71.8%71.8%70.1%69.1%68.2%68.7%68.8%69.3%71.2%72.2%73%
FIIs—0%0%0%0.8%0.8%1.3%1.3%0.5%0.6%0.6%0%
DIIs—0%0%0%0%0%0.9%0.9%0%0%0%0%
Public—28.2%28.2%29.9%30.1%30.9%29.1%29%30.2%28.2%27.2%27%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders15610690126126146134152315316301280
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Hemant Chandravadan BhagatShareholding of Promoter and Promoter Group35.5%26,78,296
Chitra Hemant BhagatShareholding of Promoter and Promoter Group16.3%12,33,192
Pranav Hemant BhagatShareholding of Promoter and Promoter Group10.1%7,61,792
Team Anamika Algo LimitedPublic Shareholding7.9%5,99,000
Prachi Pranav BhagatShareholding of Promoter and Promoter Group5.4%4,03,600
Hemant C Bhagat HufShareholding of Promoter and Promoter Group2%1,48,576
Prashant A Thakkar HufPublic Shareholding1.6%1,24,000
Mahesh C BhagatShareholding of Promoter and Promoter Group1.6%1,20,000
Riddhi Abhinav ChhedaPublic Shareholding1.6%1,18,000
Multiply Finvest Private LimitedPublic Shareholding1.1%86,000
First Rate Investments Private LimitedPublic Shareholding1.1%85,000
Jay Hemant BhagatShareholding of Promoter and Promoter Group1.1%83,600
Khyati Pradeep JoshiPublic Shareholding1.1%79,000
Padmaben Chandravadan BhagatShareholding of Promoter and Promoter Group0.5%40,000
Naynaben Chandravadan BhagatShareholding of Promoter and Promoter Group0.4%32,000
Lopa Mahesh BhagatShareholding of Promoter and Promoter Group0.1%8,000
Board of Directors
NameDesignationYear
Hemant C BhagatChairman / Executive Director / M D / Promoter2025
Pranav H BhagatWTD & Executive Director2025
Prachi Pranav BhagatExecutive Director & CFO2025
Ravindra Gajanan AwatiIndependent Non Exe. Director2025
Abha Praveen DoshiIndependent Non Exe. Director2025
Rajni DawaniCompany Sec. & Compli. Officer2025
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10988
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-05Board Meetings—
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
202600024024
202600023024
2026000001
Insider / Designated-Person Trades

1 recent disclosure(s)

Prachi Pranav BhagatAcquisition · 62,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market12/07/2024 · 7,65,000
Company Information
Incorporated2003
ChairmanHemant C Bhagat
AuditorA Y & Company
Investor Email[email protected]
🌐 www.cbcpharma.com ↗

📍 323-F Bhagat Bhuvan, Dr Ambedkar Road Matunga (E), Mumbai, Maharashtra, 400019

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

Gian Life Care LimitedArtemis Medicare ServicesSumitomo ChemicalTranway21 Technologies LimitedVardhan Capital & Finance Ltd.Universus Photo ImagingsOctavius Plantations LimitedCohance LifesciencesSM Auto Stamping LimitedSBI CardsRO Jewels LimitedCospower Engineering LimitedAll “54” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search